Bayer announced the launch of Bayer Co.Lab AdVenture, a major extension of their global life sciences incubator network meant to connect biotechnological startups with vanguard venture capital firms worldwide.
AstraZeneca announced today positive top-line results from the Phase III TULIP-SC study, assessing the subcutaneous administration of Saphnelo (anifrolumab) in patients with systemic lupus erythematosus (SLE).The interim analysis met the...
one of the largest private sector healthcare services companies in India, and Medtronic, a global leader in healthcare technology
ZyVet Animal Health, a part of Zydus Pharmaceuticals (USA), and the leader in affordable generic animal medicines, has just announced the debut of the first FDA-approved generic phenylpropanolamine hydrochloride tablets.
Mankind Pharma joins hands with OpenAI to embed advanced AI across its value chain, transforming sales, R&D, manufacturing, and healthcare innovation.
Biocon Biologics Ltd. has received FDA approval for its denosumab biosimilars, Bosaya and Aukelso, marking a major milestone in expanding affordable biologic therapies in the U.S.
Lupin, a pharmaceutical company based in Mumbai, announced on Wednesday that the US Food and Drug Administration (US FDA) had approved a generic version of Lenalidomide capsules in many strengths, including 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25
HCG Manavata Cancer Centre (HCGMCC) confirms its dedication to fighting prostate cancer, one of the most common cancers among men in India, as the globe recognizes prostate cancer awareness month this September
In order to transform healthcare concepts into significant, market-ready solutions, the Andhra Pradesh MedTech Zone (AMTZ) has introduced the Innovation Passport (i-Passport), a unique single-access gateway.
The government has planned for a Promotion of Research and Innovation in Pharma MedTech (PRIP) scheme to be rolled out this month.